FDA Inspection 1249683 — Amicogen (China) Biopharm Co., Ltd.
The FDA completed an inspection of Amicogen (China) Biopharm Co., Ltd. on Aug 30, 2024 in Jining. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 30, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Jining (China)